Vaxart (VXRT) Stock Forecast For 2023 to 2032
Are you interested in Vaxart, Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the VXRT stock price in 2022-2027. Is VXRT a good long-term stock? When should I take profit in Vaxart stock? Buy or sell stock? Will VXRT stock price go up? What are analysts’ forecasts for VXRT stock?
About Vaxart (NASDAQ: VXRT) Stock
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes a norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1 and GII.4 norovirus strains; seasonal influenza vaccine,
Which is in Phase II clinical trial for the treatment of H1 influenza infection; respiratory syncytial virus vaccine; and coronavirus vaccine, which is in Phase II clinical trial for the treatment of SARS-CoV-2 infection. It also develops therapeutic vaccines for cervical cancer and dysplasia caused by human papillomavirus. The company is headquartered in South San Francisco, California.
Big movements in Vaxart stock price
The Vaxart stock price fell by -5.41% on the last day (Wednesday, 12th Oct 2022) from $1.85 to $1.75. During the last trading day, the stock fluctuated 10.00% from a day low at $1.70 to a day high of $1.87. The price has fallen in 7 of the last 10 days and is down by -24.89% for this period.
Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -2 million shares and in total, 3 million shares were bought and sold for approximately $4.86 million.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -49.44% during the next 3 months and, with a 90% probability hold a price between $0.66 and $1.35 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Forecast & Signals
Furthermore, there is a buy signal from the 3-month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Vaxart stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock.
Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.96 and $2.51. A break-up above any of these levels will issue buy signals.
A sell signal was issued from a pivot top point on Wednesday, September 28, 2022, and so far it has fallen -24.89%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Insiders in Vaxart are quite confident about buying more shares
In the last 100 trades, there were 3.34 million shares bought and 1.15 million shares sold. The last trade was made 49 days ago by Heron Elaine J who bought 88.45 thousand shares. A large number of stocks bought compared to stocks sold indicates that the insiders believe there is a potential good upside. In some cases, larger purchases can be explained by the due date for stock options.
Financial Data for Vaxart stock
| Sector | Healthcare |
| Website | https://vaxart.com |
| currency | USD |
| Market Cap | 221385504 |
| Held Percent By Insiders | 0.868% |
| Held Percent By Institutions | 36.055002% |
| Forward PE | -1.8817204 |
| Enterprise Value | 1.17169672E8 |
| Enterprise To Ebitda | -1.333 |
| Enterprise To Revenue | 326.378 |
| Average 10-day Volume | 3185650 |
| Average Volume | 2767278 |
| Fifty-Two Week High | $8.13 |
| Fifty-Two Week Low | $1.7 |
VXRT : Vaxart stock forecast, predictions, and share price target for 2022 to 2032
The 2 Wall Street analysts offering Vaxart stock forecast in the last 6 months have an average price target of $7.0 with a high forecast of $8.0 and a low forecast of $6.0. The average Vaxart stock forecast represents a 300.0% increase from the last price of $1.75.
| year | Average | Low | High | Change from the close on 2022-10-12 |
|---|---|---|---|---|
| 2023 | $1.78 | $1.62 | $1.9 | 1.93% |
| 2024 | $1.52 | $1.46 | $1.64 | -13.05% |
| 2025 | $1.61 | $1.49 | $1.72 | -7.88% |
| 2026 | $1.58 | $1.54 | $1.64 | -9.53% |
| 2027 | $1.88 | $1.66 | $2.36 | 7.62% |
| 2028 | $4.1 | $2.57 | $5.58 | 134.13% |
| 2029 | $7.64 | $5.82 | $9.48 | 336.63% |
| 2030 | $10.45 | $9.7 | $10.97 | 496.89% |
| 2031 | $11.28 | $11.03 | $11.47 | 544.3% |
| 2032 | $14.01 | $11.5 | $15.05 | 700.5% |
For Vaxart stock forecast for 2023, 12 predictions are offered for each month of 2023 with an average Vaxart stock forecast of $1.78, a high forecast of $1.9, and a low forecast of $1.62. The average Vaxart stock forecast for 2023 represents a 1.93% increase from the last price of $1.75.
For Vaxart stock forecast for 2025, 12 predictions are offered for each month of 2025 with an average Vaxart stock forecast of $1.61, a high forecast of $1.72, and a low forecast of $1.49. The average Vaxart stock forecast for 2025 represents a -7.88% decrease from the last price of $1.75.
For Vaxart stock forecast for 2027 (5 years), 12 predictions are offered for each month of 2027 with an average Vaxart stock forecast of $1.88, a high forecast of $2.36, and a low forecast of $1.66. The average Vaxart stock forecast for 2027 represents a 7.62% increase from the last price of $1.75.
For Vaxart stock forecast for 2030, 12 predictions are offered for each month of 2030 with an average Vaxart stock forecast of $10.45, a high forecast of $10.97, and a low forecast of $9.7. The average Vaxart stock forecast for 2030 represents a 496.89% increase from the last price of $1.75.
For Vaxart stock forecast for 2032 (10 years), 10 predictions are offered for each month of 2032 with an average Vaxart stock forecast of $14.01, a high forecast of $15.05, and a low forecast of $11.5. The average Vaxart stock forecast for 2032 represents a 700.5% increase from the last price of $1.75. Please, see more forecasts below.
VXRT: Vaxart stock forecast for 2022
| Date | Price Target | Change |
|---|---|---|
| 2022 Nov. | $1.68 | -3.84% |
| 2022 Dec. | $1.63 | -3.43% |
VXRT: Vaxart stock forecast for 2023
| Date | Price Target | Change |
|---|---|---|
| 2023 Jan. | $1.62 | -0.38% |
| 2023 Feb. | $1.66 | 2.64% |
| 2023 Mar. | $1.73 | 4.01% |
| 2023 Apr. | $1.80 | 4.03% |
| 2023 May. | $1.85 | 3.03% |
| 2023 Jun. | $1.89 | 1.99% |
| 2023 Jul. | $1.90 | 0.54% |
| 2023 Aug. | $1.88 | -0.95% |
| 2023 Sep. | $1.85 | -1.83% |
| 2023 Oct. | $1.80 | -2.71% |
| 2023 Nov. | $1.74 | -3.01% |
| 2023 Dec. | $1.69 | -3.03% |
VXRT: Vaxart stock forecast for 2024
| Date | Price Target | Change |
|---|---|---|
| 2024 Jan. | $1.64 | -2.81% |
| 2024 Feb. | $1.60 | -2.41% |
| 2024 Mar. | $1.57 | -2.08% |
| 2024 Apr. | $1.54 | -1.71% |
| 2024 May. | $1.53 | -0.95% |
| 2024 Jun. | $1.52 | -0.50% |
| 2024 Jul. | $1.51 | -0.90% |
| 2024 Aug. | $1.49 | -1.04% |
| 2024 Sep. | $1.47 | -1.22% |
| 2024 Oct. | $1.46 | -0.95% |
| 2024 Nov. | $1.46 | -0.18% |
| 2024 Dec. | $1.47 | 0.78% |
VXRT: Vaxart stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Jan. | $1.49 | 1.82% |
| 2025 Feb. | $1.54 | 3.02% |
| 2025 Mar. | $1.62 | 5.08% |
| 2025 Apr. | $1.72 | 6.34% |
| 2025 May. | $1.71 | -0.85% |
| 2025 Jun. | $1.67 | -1.96% |
| 2025 Jul. | $1.65 | -1.50% |
| 2025 Aug. | $1.63 | -1.32% |
| 2025 Sep. | $1.61 | -1.23% |
| 2025 Oct. | $1.59 | -1.15% |
| 2025 Nov. | $1.57 | -1.00% |
| 2025 Dec. | $1.56 | -0.85% |
VXRT: Vaxart stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $1.55 | -0.59% |
| 2026 Feb. | $1.54 | -0.26% |
| 2026 Mar. | $1.55 | 0.10% |
| 2026 Apr. | $1.55 | 0.43% |
| 2026 May. | $1.56 | 0.62% |
| 2026 Jun. | $1.57 | 0.70% |
| 2026 Jul. | $1.58 | 0.66% |
| 2026 Aug. | $1.59 | 0.66% |
| 2026 Sep. | $1.61 | 0.68% |
| 2026 Oct. | $1.62 | 0.70% |
| 2026 Nov. | $1.63 | 0.73% |
| 2026 Dec. | $1.64 | 0.77% |
VXRT: Vaxart stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $1.66 | 0.86% |
| 2027 Feb. | $1.67 | 1.01% |
| 2027 Mar. | $1.69 | 1.21% |
| 2027 Apr. | $1.72 | 1.47% |
| 2027 May. | $1.75 | 1.80% |
| 2027 Jun. | $1.79 | 2.20% |
| 2027 Jul. | $1.83 | 2.69% |
| 2027 Aug. | $1.89 | 3.30% |
| 2027 Sep. | $1.97 | 4.07% |
| 2027 Oct. | $2.07 | 5.02% |
| 2027 Nov. | $2.20 | 6.14% |
| 2027 Dec. | $2.36 | 7.47% |
VXRT: Vaxart stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $2.57 | 8.93% |
| 2028 Feb. | $2.83 | 9.84% |
| 2028 Mar. | $3.11 | 9.91% |
| 2028 Apr. | $3.40 | 9.39% |
| 2028 May. | $3.69 | 8.57% |
| 2028 Jun. | $3.98 | 7.77% |
| 2028 Jul. | $4.26 | 7.09% |
| 2028 Aug. | $4.54 | 6.54% |
| 2028 Sep. | $4.81 | 6.05% |
| 2028 Oct. | $5.08 | 5.52% |
| 2028 Nov. | $5.33 | 5.07% |
| 2028 Dec. | $5.58 | 4.69% |
VXRT: Vaxart stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $5.82 | 4.29% |
| 2029 Feb. | $6.06 | 3.98% |
| 2029 Mar. | $6.31 | 4.15% |
| 2029 Apr. | $6.62 | 4.92% |
| 2029 May. | $7.01 | 5.95% |
| 2029 Jun. | $7.45 | 6.27% |
| 2029 Jul. | $7.89 | 5.83% |
| 2029 Aug. | $8.27 | 4.93% |
| 2029 Sep. | $8.62 | 4.20% |
| 2029 Oct. | $8.94 | 3.68% |
| 2029 Nov. | $9.23 | 3.23% |
| 2029 Dec. | $9.48 | 2.76% |
VXRT: Vaxart stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $9.70 | 2.32% |
| 2030 Feb. | $9.89 | 1.94% |
| 2030 Mar. | $10.06 | 1.66% |
| 2030 Apr. | $10.20 | 1.46% |
| 2030 May. | $10.34 | 1.31% |
| 2030 Jun. | $10.46 | 1.18% |
| 2030 Jul. | $10.57 | 1.05% |
| 2030 Aug. | $10.67 | 0.94% |
| 2030 Sep. | $10.75 | 0.83% |
| 2030 Oct. | $10.84 | 0.75% |
| 2030 Nov. | $10.91 | 0.67% |
| 2030 Dec. | $10.97 | 0.60% |
VXRT: Vaxart stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $11.03 | 0.54% |
| 2031 Feb. | $11.09 | 0.49% |
| 2031 Mar. | $11.14 | 0.45% |
| 2031 Apr. | $11.18 | 0.42% |
| 2031 May. | $11.23 | 0.39% |
| 2031 Jun. | $11.27 | 0.37% |
| 2031 Jul. | $11.31 | 0.35% |
| 2031 Aug. | $11.35 | 0.33% |
| 2031 Sep. | $11.38 | 0.30% |
| 2031 Oct. | $11.41 | 0.28% |
| 2031 Nov. | $11.44 | 0.26% |
| 2031 Dec. | $11.47 | 0.25% |
VXRT: Vaxart stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $11.50 | 0.26% |
| 2032 Feb. | $11.55 | 0.43% |
| 2032 Mar. | $14.22 | 23.12% |
| 2032 Apr. | $14.34 | 0.87% |
| 2032 May. | $14.44 | 0.69% |
| 2032 Jun. | $14.56 | 0.79% |
| 2032 Jul. | $14.68 | 0.85% |
| 2032 Aug. | $14.81 | 0.85% |
| 2032 Sep. | $14.93 | 0.83% |
| 2032 Oct. | $15.05 | 0.78% |
IMPORTANT IF YOU'RE BUYING VAXART! | VXRT VAXART STOCK ANALYSIS | VXRT PRICE & PREDICTIONS
Conclusion
Money Luster predicts future values using technical analysis of a large number of analytical parameters. VXRT stock returns are also expected based on historical data. According to our research, VXRT stock is an excellent long-term investment. VXRT's share price has been in a bull cycle for the past year. Vaxart, Inc.'s stock trend is positive.
Frequently Asked Questions?
What is analysts' consensus 12-month price estimate for VXRT?
Vaxart's 12-month average price target is $7.00 based on analyst ratings.
What is the upside potential for VXRT?
Based on the average price objective of the analysts, Vaxart has a 295.48% upside potential.
Can I view the stocks that the top experts are recommending?
Yes, you may use the Analysts' Top Stocks feature to view stocks with a Strong Buy or Strong Sell consensus recommendation from the best-performing analysts.
How do I keep up with top Wall Street analysts' stock ratings?
The top 100 Wall Street analysts are listed in our Expert Center, where you may also follow the analysts of your choosing. For additional information on their stock ratings and to view their stock-by-stock performance, view their profiles.
Should I buy, sell, or hold VXRT?
Based on 2 buy ratings, 1 hold rating, and 0 sell recommendations, the consensus rating for Vaxart is Moderate Buy.
What is the pricing point for Vaxart?
Vaxart's average price goal is $7.00. This is based on three 12-month price targets released in the previous three months by Wall Street analysts. The $8.00 analyst price prediction is the highest, while the $6.00 projection is the lowest. From the current price of $1.77, the average price objective reflects an increase of 295.48%.
What do experts think about Vaxart?
The consensus analyst rating for Vaxart is "Moderate Buy." Based on the evaluations of three Wall Street analysts.
Comments
Post a Comment